Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

Scholarly Works

• Jiang, J.; Kaysar, K.; Pan, Y.; Xia, L.; Li, J. A Zeolitic Imidazolate Framework-Based Antimicrobial Peptide Delivery System with Enhanced Anticancer Activity and Low Systemic Toxicity. Pharmaceutics 2024, 16, 1591. doi:10.3390/pharmaceutics16121591
• Kumari, M.; Piyongsola; Ravi Naik, M.; Singh Rathore, H.; Kumar Shukla, A.; Iqbal Dar, A.; Ravi Kiran, A. V.; Kumari, K.; Acharya, A.; Thaggikuppe Krishnamurthy, P. Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer. International Journal of Pharmaceutics 2024, 125142. doi:10.1016/j.ijpharm.2024.125142
• Parvin, N.; Mandal, T. K.; Joo, S.-W. The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems. Pharmaceutics 2024, 16, 1366. doi:10.3390/pharmaceutics16111366
• Rodponthukwaji, K.; Thongchot, S.; Deureh, S.; Thongkleang, T.; Thaweesuvannasak, M.; Srichan, K.; Srisawat, C.; Thuwajit, P.; Nguyen, K. T.; Tadpetch, K.; Thuwajit, C.; Punnakitikashem, P. Development of cancer-associated fibroblasts-targeting polymeric nanoparticles loaded with 8-O-methylfusarubin for breast cancer treatment. International journal of pharmaceutics: X 2024, 8, 100294. doi:10.1016/j.ijpx.2024.100294
• Velásquez, F.; Frazao, M.; Diez, A.; Villegas, F.; Álvarez-Bidwell, M.; Rivas-Pardo, J. A.; Vallejos-Vidal, E.; Reyes-López, F.; Toro-Ascuy, D.; Ahumada, M.; Reyes-Cerpa, S. Salmon-IgM Functionalized-PLGA Nanosystem for Florfenicol Delivery as an Antimicrobial Strategy against Piscirickettsia salmonis. Nanomaterials (Basel, Switzerland) 2024, 14, 1658. doi:10.3390/nano14201658
• Cong, X.; Zhang, Z.; Li, H.; Yang, Y.-G.; Zhang, Y.; Sun, T. Nanocarriers for targeted drug delivery in the vascular system: focus on endothelium. Journal of nanobiotechnology 2024, 22, 620. doi:10.1186/s12951-024-02892-9
• Maskur; Wongso, H.; Humani, T. S.; Effendi, N.; Palangka, C. R.; Pujiyanto, A.; Setiawan, H.; Juliyanto, S.; Ridwan, M.; Ritawidya, R. Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies. Journal of Drug Delivery Science and Technology 2024, 100, 106104. doi:10.1016/j.jddst.2024.106104
• Jain, M.; Yu, X.; Schneck, J. P.; Green, J. J. Nanoparticle Targeting Strategies for Lipid and Polymer‐Based Gene Delivery to Immune Cells In Vivo. Small Science 2024. doi:10.1002/smsc.202400248
• Marques, A. C.; Costa, P. C.; Velho, S.; Amaral, M. H. Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles. Life (Basel, Switzerland) 2024, 14, 489. doi:10.3390/life14040489
• Lim, S. H.; Yee, G. T.; Khang, D. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier. International journal of nanomedicine 2024, 19, 2529–2552. doi:10.2147/ijn.s450853
• Singh, M. T.; Thaggikuppe Krishnamurthy, P.; Magham, S. V. Harnessing the synergistic potential of NK1R antagonists and selective COX-2 inhibitors for simultaneous targeting of TNBC cells and cancer stem cells. Journal of drug targeting 2024, 32, 258–269. doi:10.1080/1061186x.2024.2309568
• Ashour, M. M.; Mabrouk, M.; Aboelnasr, M. A.; Beherei, H. H.; Tohamy, K. M.; Das, D. B. Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges. Pharmaceutics 2023, 15, 2635. doi:10.3390/pharmaceutics15112635
• Kapare, H.; Bhosale, M.; Bhole, R. Navigating the future: Advancements in monoclonal antibody nanoparticle therapy for cancer. Journal of Drug Delivery Science and Technology 104, 106495. doi:10.1016/j.jddst.2024.106495

Explore citations to this article at